NCT05450575View on ClinicalTrials.gov

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

CompletedOBSERVATIONAL
Enrollment

5,400

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
HypertensionDyslipidemia
Interventions
DRUG

Amosartan Q tablet

Amlodipine, Losartan, Rosuvastatin

Trial Locations (1)

Unknown

Hanmi Pharmaceutical Company Limited, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY